Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2019-11-21 | 2020-02-13 | 99438 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-11-21 | 2020-01-09 | 99441 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Resolved | 2019-11-21 | 2020-01-24 | 99444 |
| TEVA-CHLOROQUINE | 250MG | TABLET | Actual shortage | 2019-11-21 | 2020-07-10 | 99447 |
| TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-11-21 | 2020-12-17 | 99450 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2019-11-21 | 2020-07-10 | 99453 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-11-28 | 2020-05-01 | 99856 |
| TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2019-11-28 | 2020-01-24 | 99929 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Actual shortage | 2019-11-28 | 2021-10-14 | 99938 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99944 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-11-28 | 2022-01-07 | 99952 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-28 | 2020-06-25 | 99955 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-28 | 2020-08-21 | 99959 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99962 |
| ACT OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-01-24 | 99965 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-01-24 | 99968 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |